Lung Cancer Foundation of America’s
Social Media Takeover on World Lung Cancer Day
Monday, August 1st, 2022
Since its inception in 2012, World Lung Cancer Day has been observed every year on August 1 in order to raise awareness of lung cancer issues and magnify the need for more lung cancer research funding. Lung Cancer Foundation of America’s social media takeover was 4 hours of lively conversations with brilliant lung cancer researchers and lung cancer patient advocates who exemplify what #livingwithlungcancer looks like.
This year, LCFA’s World Lung Cancer Day message aimed to magnify the importance of biomarker testing for newly diagnosed lung cancer patients. Watch the action!
Why biomarker testing makes a difference
“For lung cancer patients who haven’t had access to comprehensive biomarker testing and are treated with the old standard of chemotherapy, the 5-year survival rate is somewhere around 4-6%. But, thanks to advances in lung cancer research, those who have an identified biomarker who are treated with a targeted therapy, that 5-year survival rate rises to 60%.”
– Dr. Osarogiagabon, Baptist Memorial Hospital, Memphis, TN
Hear more from Dr. Osarogiagabon who wants everyone diagnosed with lung cancer to ask the question, “What is my biomarker?”
Tune in as advocates around the country use their lungs to raise awareness of the power and need for increased lung cancer research. The takeover will feature live interviews and demonstrations on LCFA’s Facebook page | LCFA’s Twitter handle | LCFA’s Instagram page
Lung Cancer Foundation of America is proud to support World Lung Cancer Day by raising awareness through a social media takeover by our dedicated Speakers Bureau and Young Investigators.
They will be sharing their stories of how they use their lungs and how lung cancer research has made a difference. We thank them for their personal commitment and how their actions will illustrate this year’s theme so well.
New research, diagnosis, and treatment breakthroughs in the last 10 years have brought new hope to patients and their families.
LCFA has been instrumental in developing a continuing public dialogue. Through annual media campaigns, LCFA has been dedicated to education and research – the route to the early diagnosis and treatment of lung cancer and, hopefully, the cure.
